ABSTRACT The current experiment was conducted to determine the effect of mycotoxin-contaminated diets with aflatoxin (AFLA) and deoxynivalenol (DON) and dietary inclusion of deactivation compound on layer hen performance during a 10-wk trial. The experimental design consisted of a 4 × 2 factorial with 4 toxin levels: control, low (0.5 mg/kg AFLA + 1.0 mg/kg DON), medium (1.5 mg/kg AFLA + 1.5 mg/kg DON), and high (2.0 mg/kg AFLA + 2.0 mg/kg DON) with or without the inclusion of deactivation compound. Three hundred eighty-four 25-wk-old laying hens were randomly assigned to 1 of the 8 treatment groups. Birds were fed contaminated diets for a 6-wk phase of toxin administration followed by a 4-wk recovery phase, when all birds were fed mycotoxin-free diets. Twelve hens from each treatment were subjected to necropsy following each phase. Relative liver and kidney weights were increased (P < 0.05) at the medium and high toxin levels following the toxin phase, but the deactivation compound reduced (P < 0.05) relative liver and kidney weights following the recovery period. The high toxin level decreased (P < 0.05) feed consumption and egg production during the toxin period, whereas the deactivation compound increased (P < 0.05) egg production during the first 2 wk of the toxin phase. Egg weights were reduced (P < 0.05) in hens fed medium and high levels of toxin. An interaction existed between toxin level and deactivation compound inclusion with regard to feed conversion (g of feed/g of egg). High inclusion level of toxins increased feed conversion compared with the control diet, whereas deactivation compound inclusion reduced feed conversion to a level comparable with the control. These data indicate that deactivation compound can reduce or eliminate adverse effects of mycotoxicoses in peak-performing laying hens.
INTRODUCTION
Mycotoxins are secondary metabolites of molds that produce approximately 400 different mycotoxins by more than 100 molds (Kabak et al., 2006) . Aflatoxins (AFLA) B 1 , B 2 , G 1 , and G 2 are produced by fungi of Aspergillus, Penicillium, Rhizopus, Mucor, and Streptomyces species, which are the main contaminants of plants and plant products (Smith, 2002) . The susceptibility of poultry to these particular mycotoxins ranges from ducklings > turkey poults > goslings > pheasant chicks > chickens (Muller et al., 1970) . The median lethal dose (LD50) for chickens is estimated to be between 6.5 and 16.5 mg/kg (Smith and Hamilton, 1970) . In laying hens, AFLA impairs all important production parameters including weight gain, feed intake, feed conversion efficiency, egg production, and male and female reproductive performance. Reduced egg production, enlarged liver, and increased liver fat are the most prominent manifestations of aflatoxicosis in layers (Leeson et al., 1995) .
Deoxynivalenol (DON) is trichothecene mycotoxin produced by fungi of Fusarium sp. (F. graminearum, F. culmorum) , and it is one of the most widely distributed mycotoxins in food and feed worldwide. Deoxynivalenol is a well-known inhibitor of protein synthesis. The toxin binds to peptidyl transferase (Feinberg and McLaughlin, 1989) , inhibits the synthesis of RNA and DNA via binding to the ribosome, and also affects cell membranes. It is assumed that cells and tissues with high protein turnover rates such as the small intestine, liver, and the immune system are most severely affected by DON intoxication (Döll et al., 2003) . The LD50 for 1-d-old chickens is estimated to be 140 mg/kg (Huff et al., 1981) , approximately 10 times lower toxicity than AFLA. Deoxynivalenol is well tolerated by laying hens. One study demonstrated feeding diets naturally contaminated with 5 mg/kg of DON for 25 wk did not show adverse effects on health or productivity (Hamil-ton et al., 1985) . Natural contamination of grains often results in the presence of multiple mycotoxins. Multiple manuscripts have documented observed contamination of grains with AFLA and DON (Hagler et al., 1984; Abbas et al., 2002) .
Aluminosilicates can effectively adsorb AFLA but are not effective against trichothecene mycotoxins, such as DAS or T-2 toxin (Kubena et al., 1993; Phillips, 1999) . A more specific dietary treatment has been recently developed using enzymes capable of inactivating the trichothecenes through modification of the basic trichothecene structure. The inhibitory activity of trichothecenes requires the presence of the C-12,13 epoxide, and opening of the 12,13-epoxide ring, which results in loss of any apparent toxicity (Binder et al., 2000) . The aim of the present study was to investigate the adverse effects of the combination of dietary AFLA and DON in laying hens and possible effectiveness of commercially available mycotoxin deactivation product.
MATERIALS AND METHODS

Birds
To evaluate the influence of mycotoxin-contaminated diets and effectiveness of a potential deactivating agent (Mycofix Select, Biomin GmbH, Herzogenburg, Austria) on peak producing laying performance and relative organ weight, 450 Lohmann LSL-LITE pullets (14 wk of age) were obtained from a local egg production facility and moved to the Texas A&M University Poultry Research Center. Pullets were allowed to acclimate to the research facility and begin egg production before the start of the trial. Hens were housed in commercial type-laying cages at densities that met acceptable placement densities outlined by the 2007-2008 United Egg Producers Animal Welfare Guidelines (United Egg Producers, 2008) . All husbandry practices, including the space requirements for unrestricted feeder and water access, followed these published guidelines and were conducted in accordance with an animal use protocol approved by the Institutional Animal Care and Use Committee at Texas A&M University. Upon arrival at the research facility, pullets were fed a corn-soybeanbased developer ration that met or exceeded nutrient recommendations specified in the Lohmann LSL-LI-TE management guide. Subsequent feed and lighting changes following the management guide were made allowing for the initiation of egg production. Birds were placed in commercial type cages located in a 2 windowless, environmentally controlled laying facilities. The cages used during the trial had dimensions of 30.5 × 50.8 cm, which allowed for 1,548 cm 2 of rearing space. Three pullets were placed per cage to achieve 516 cm 2 of rearing space per bird.
Experimental Design
The experimental design consisted of a 4 × 2 factorial design evaluating multiple toxin levels combined with and without mycotoxin deactivating agent inclusion yielding a total of 8 treatment groups. Four toxin administration levels were evaluated included a control (diet free of mycotoxin), low (0.5 mg/kg AFLA + 1.0 mg/kg DON), medium (1.5 mg/kg AFLA + 1.5 mg/kg DON), and high (2.0 mg/kg AFLA + 2.0 mg/kg DON) with and without the inclusion of deactivation compound (2.27 kg/ton). Each treatment used 16 replicate cages with each replicate containing 3 birds. Treatments were assigned to individual replicates based on 24-wk BW and egg production levels to ensure that each treatment began the experiment on 25 wk with statistically equivalent BW and egg production levels.
Mycotoxin Contamination and Administration
A corn sample was obtained and screened for mycotoxin level via HPLC analysis for aflatoxin (including B 1 , B 2 , G 1 , and G 2 ), DON, zearalenone (ZON), fumonisin (including B 1 and B 2 ), and ochratoxin A and determined to have a DON concentration of 4.0 mg/kg with all other tested mycotoxins below the level of detection. The naturally contaminated corn and purified aflatoxin in rice culture were used to reach experimental contamination levels. To increase contamination levels of the diets, contaminated corn and rice culture spared noncontaminated corn. Basal diets of each contamination level were divided into 2 subsamples, and the deactivating agent was added to one portion. Three samples of each treatment (500 g) were collected for mycotoxin determination via HPLC analysis (Table 1 ). In short, purification was accomplished by using immunoaffinity clean-up columns (Romer Labs, Vienna, Austria). The HPLC analyses were performed with 1100 and 1200 series HPLC systems, each equipped with a UV detector (G1314B) and a fluorescence detector (G1321A), or a mass spectrometer (G1946D, Agilent Technologies, Waldbronn, Germany). Depending on the optical properties of the mycotoxin, several detectors were used (e.g., the mycotoxins such as ochratoxin A or ZON and AFLA after derivatization show a natural fluorescence, thus they were detected with high sensitivity by the use of fluorescence detectors). Others such as type B trichothecenes (e.g., DON) absorb UV light of a certain wavelength and were measured by a UV detector. For those mycotoxins that do not emit fluorescence light or absorb UV light (such as FUM), a mass spectrometer (single quadrupole) was used for determination.
The experiment was initiated at 25 wk of age with feeding of each dietary treatment to producing laying hens for 6 consecutive weeks. Following the 6-wk administration period, all laying hens were fed a diet devoid of all mycotoxins for a subsequent 4 wk (recovery period) at which time the experiment was concluded. At the conclusion of the 6-wk toxin administration period and at the conclusion of the study, 4 replicates per treatment (12 total laying hens) were killed for the determination of relative liver, kidney, and spleen weight.
Parameters evaluated throughout the experiment included feed consumption, egg production, mortality, BW gain, and relative organ weight.
Statistical Analysis
Data were analyzed via a 4 (toxin) × 2 (deactivation compound) factorial ANOVA using the GLM procedure with main effect means deemed significantly determined at P < 0.05 (SPSS V 18.0, SPSS Inc., Chicago, IL). Main effect means were separated using Duncan's multiple range test. In cases in which a significant interaction was present between toxin level and deactivation compound inclusion, data were subjected to a 1-way ANOVA with means deemed different at P < 0.05. In these cases, individual treatment means were separated using Duncan's multiple range test.
RESULTS
Differences in feed consumption were observed during the third and fourth week of toxin administration as well as the fifth and sixth week of administration (Table 2 ). During wk 3 and 4 of toxin administration, reductions (P < 0.05) were observed in the high toxin group compared with the other administration groups, whereas the low and medium levels increased (P < 0.05) feed consumption compared with the control. During the fifth and sixth week of inclusion, an interaction was observed between toxin level and deactivation compound inclusion. A reduction (P < 0.05) was observed in the control + deactivation compound diet compared with the control treatment. The high toxin level again yielded the lowest feed consumption, whereas the addition of the deactivation compound to this diet increased feed consumption comparable with the control + deactivation compound treatment. Feed consumption for the entire toxin administration period was reduced (P < 0.05) in the high toxin diet compared with all other toxin levels. Upon removal of the mycotoxin from the diet, feed consumption in the high toxin increased to a level comparable with all other treatment groups. No effect of deactivating compound on feed consumption was observed during the 4-wk recovery period.
Deactivation compound inclusion increased egg production compared with the nondeactivation compound groups during the first 2 wk of administration (Table  3 ). An interaction (P < 0.05) was observed during wk 4 of egg production between toxin level and deactivation compound inclusion (data not shown). During this period, a reduction (P < 0.05) in egg production in the high toxin administration group was observed compared with the high toxin + deactivation compound group. During the fifth and sixth week of toxin administration, the high toxin diet reduced (P < 0.05) egg production compared with all other toxin levels. For the entire toxin administration period, the high toxin level reduced (P < 0.05) egg production compared with all other toxin groups. Similar to feed consumption, egg production during the recovery period in the high toxin administration treatments increased following the removal of mycotoxins to a level comparable with all other treatments.
When evaluating the data over the entire toxin administration period, the high toxin diet yielded the highest feed conversion (P < 0.05) needed to produce a gram of egg (Table 4 ). The addition of deactivation compound to the high toxin diet reduced the amount of feed needed to produce a gram of egg to a level comparable with the control diet. A similar relationship was observed during the combination of the third and fourth week of administration where deactivation compound addition to the high toxin diet reduced the amount of feed needed to produce a gram of egg to a level comparable with the control diet. Apart from feed consumption and egg production, the high toxin group was associated with the residual effect of toxin administration during the 4-wk recovery period, resulting in an increase in the amount of feed needed to produce a gram of egg compared with other toxin levels. 1 Contaminated diets were fed for 6 consecutive weeks followed by 4 recovery periods in which the diet was free of mycotoxins. 2 Mycofix Select (Biomin GmbH, Herzogenburg, Austria) inclusion of 2.27 kg/ton. 3 Target level of 0.5 mg/kg B1 aflatoxin and 1.0 mg/kg deoxynivalenol. 4 Target level of 1.5 mg/kg B1 aflatoxin and 1.5 mg/kg deoxynivalenol. 5 Target level of 2.0 mg/kg B1 aflatoxin and 2.0 mg/kg deoxynivalenol. Following the toxin administration period, relative hen liver and kidney weights were increased (P < 0.05) due to toxins administration at the medium and high levels compared with the controls, whereas administration of the low toxin diet did not affect these parameters (Table 6 ). Relative liver weight in birds fed the high toxin diet were increased (P < 0.05) compared with all other treatment groups. Medium toxin administration increased (P < 0.05) relative liver weight compared with the control and low level of administration. Reductions (P < 0.05) in relative liver and kidney weights were observed in deactivation-compoundfed birds compared with birds not supplemented with deactivation compound following the recovery period. Increases (P < 0.05) in BW gain were observed with medium toxin administration compared with the control for the duration of the experiment (Table 5) .
DISCUSSION
The dietary inclusion of a combination of AFLA and DON negatively affected feed consumption, egg production, and feed conversion in a concentration-related manner when measured in commercial-strain laying hens during peak production. Others researchers have reported similar decreases in performance parameters in laying hens consuming mycotoxin-contaminated feeds. Branton et al. (1989) reported decreased egg production in laying hens fed a grain sorghum diet contaminated with ZON and DON. Similar observations were reported by Danicke et al. (2002) with Fusarium-contaminated corn assayed to contain DON and ZON. Laying hens fed contaminated corn resulted in decreased feed consumption, daily egg mass, and serum antibody titers to Newcastle disease virus (Danicke et al., 2002) . Reductions in egg production attributed to AFLA-contaminated feed have also been reported (Fernandez et al., 1994) . Reductions in performance-related parameters may be associated with decreased intestinal functionality associated with mycotoxin feeding as described by Applegate et al. (2009) , which observed alterations in intestinal morphology and apparent digestible energy. Additionally, exposure to DON-contaminated feeds negatively affect animal health and performance through inhibition of intestinal sodium glucose-linked transporter 1 (Awad et al., 2007a,b) . The observed reductions in performance in the current trial are most likely attributable to the inclusion of AFLA or the combination of multiple mycotoxins because contamination only with DON has been reported not to reduce egg production and feed intake (Bergsjø et al., 1993) , which were both observed in the current trial.
Further, mycotoxin inclusion also increased relative liver and kidney weights, an indicator of toxicity associated with mycotoxin ingestion. Increased relative liver weight associated with mycotoxin feeding has been 1 Contaminated diets were fed for 6 consecutive weeks followed by 4 recovery periods in which the diet was free of mycotoxins. a-c Main effect and treatment means with different superscripts differ at P ≤ 0.05. 1 Contaminated diets were fed for 6 consecutive weeks followed by 4 recovery periods in which the diet was free of mycotoxins. 2 Mycofix Select (Biomin GmbH, Herzogenburg, Austria) inclusion of 2.27 kg/ton. 3 Target level of 0.5 mg/kg B1 aflatoxin and 1.0 mg/kg deoxynivalenol. 4 Target level of 1.5 mg/kg B1 aflatoxin and 1.5 mg/kg deoxynivalenol. 5 Target level of 2.0 mg/kg B1 aflatoxin and 2.0 mg/kg deoxynivalenol.
reported (Fernandez et al., 1994) and is an expected observation as AFLA and its metabolites are present at a 10-fold higher level in liver tissue compared with muscle tissue (Bintvihok et al., 2002) . Aflatoxin contamination is of considerable importance in laying hen diets due to the possibility of deposition of metabolites in the egg (Oliveira et al., 2000) . Mycotoxin feeding, specifically AFLA, causes histological lesions in renal structures, ultimately modifying renal function by either inducing lesions or altering ion transport resulting in increases in Ca, Na, and phosphate fraction excretions (Martínez-de-Anda et al., 2010) . Of the parameters affected by toxin administration, feed conversion, egg production, and feed consumption were consistently improved when deactivation compound was included in the high toxin administration diet. Similarly, inclusion of the deactivating compound reduced relative liver and kidney weights compared with observed increases in relative weights in nondeactivation-compound-administered toxin-challenged hens. The addition of the deactivating compound used in the current study has previously been observed to positively influence production parameters in laying hens in the presence of mycotoxins (Danicke et al., 2002) . Taken together, these observations suggest that the dietary inclusion of deactivation compound can spare in-production hens from performance losses and physiological insult when ingesting diets contaminated with a combination of AFLA B 1 and DON.
